These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 9929515)
1. Characterization of eprinomectin N-deacetylase in rats. Zeng Z; Andrew NW Drug Metab Dispos; 1999 Feb; 27(2):269-73. PubMed ID: 9929515 [TBL] [Abstract][Full Text] [Related]
2. Deacetylation of cinobufagin by rat liver. Zhang L; Aoki K; Yoshida T; Kuroiwa Y Drug Metab Dispos; 1992; 20(1):52-5. PubMed ID: 1346996 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and metabolism of eprinomectin in cats when administered in a novel topical combination of fipronil, (S)-methoprene, eprinomectin and praziquantel. Kvaternick V; Kellermann M; Knaus M; Rehbein S; Rosentel J Vet Parasitol; 2014 Apr; 202(1-2):2-9. PubMed ID: 24703069 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of a cytosolic arylacylamidase metabolizing thiacetazone. Khanna P; Kaur S; Sanwal GG; Ali B J Pharmacol Exp Ther; 1992 Sep; 262(3):1225-31. PubMed ID: 1382131 [TBL] [Abstract][Full Text] [Related]
6. Comparison between procaine and isocarboxazid metabolism in vitro by a liver microsomal amidase-esterase. Moroi K; Sato T Biochem Pharmacol; 1975 Aug; 24(16):1517-21. PubMed ID: 8 [No Abstract] [Full Text] [Related]
7. In vitro metabolism of tirilazad mesylate in male and female rats. Contribution of cytochrome P4502C11 and delta 4-5 alpha-reductase. Wienkers LC; Steenwyk RC; Mizsak SA; Pearson PG Drug Metab Dispos; 1995 Mar; 23(3):383-92. PubMed ID: 7628305 [TBL] [Abstract][Full Text] [Related]
8. Pretreatment with the inducers rifampicin and phenobarbital alters ivermectin gastrointestinal disposition. Ballent M; Lifschitz A; Virkel G; Mate L; Lanusse C J Vet Pharmacol Ther; 2010 Jun; 33(3):252-9. PubMed ID: 20557442 [TBL] [Abstract][Full Text] [Related]
9. Isocarboxazid metabolism in vitro by liver microsomal carboxylesterase of monkey. Moroi K; Kuga T Biochem Pharmacol; 1980 Jun; 29(11):1491-6. PubMed ID: 6772191 [No Abstract] [Full Text] [Related]
10. Oxidative metabolism of monensin in rat liver microsomes and interactions with tiamulin and other chemotherapeutic agents: evidence for the involvement of cytochrome P-450 3A subfamily. Nebbia C; Ceppa L; Dacasto M; Carletti M; Nachtmann C Drug Metab Dispos; 1999 Sep; 27(9):1039-44. PubMed ID: 10460804 [TBL] [Abstract][Full Text] [Related]
11. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver. Amato G; Longo V; Mazzaccaro A; Gervasi PG Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925 [TBL] [Abstract][Full Text] [Related]
12. Characterization of deltamethrin metabolism by rat plasma and liver microsomes. Anand SS; Bruckner JV; Haines WT; Muralidhara S; Fisher JW; Padilla S Toxicol Appl Pharmacol; 2006 Apr; 212(2):156-66. PubMed ID: 16169030 [TBL] [Abstract][Full Text] [Related]
13. Arylacetamide deacetylase activity towards monoacetyldapsone. Species comparison, factors that influence activity, and comparison with 2-acetylaminofluorene and p-nitrophenyl acetate hydrolysis. Preuss CV; Svensson CK Biochem Pharmacol; 1996 Jun; 51(12):1661-8. PubMed ID: 8687481 [TBL] [Abstract][Full Text] [Related]
14. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A. Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860 [TBL] [Abstract][Full Text] [Related]
15. Specificity of procaine and ester hydrolysis by human, minipig, and rat skin and liver. Jewell C; Ackermann C; Payne NA; Fate G; Voorman R; Williams FM Drug Metab Dispos; 2007 Nov; 35(11):2015-22. PubMed ID: 17664252 [TBL] [Abstract][Full Text] [Related]
16. Conversion of retinol to retinal by rat liver microsomes. Shih TW; Hill DL Drug Metab Dispos; 1991; 19(2):332-5. PubMed ID: 1676632 [TBL] [Abstract][Full Text] [Related]
17. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation. Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124 [TBL] [Abstract][Full Text] [Related]
18. Cytochrome P-450 2E1 is not the sole catalyst of chlorzoxazone hydroxylation in rat liver microsomes. off. Jayyosi Z; Knoble D; Muc M; Erick J; Thomas PE; Kelley M J Pharmacol Exp Ther; 1995 Jun; 273(3):1156-61. PubMed ID: 7791086 [TBL] [Abstract][Full Text] [Related]
19. Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions. Slatter JG; Su P; Sams JP; Schaaf LJ; Wienkers LC Drug Metab Dispos; 1997 Oct; 25(10):1157-64. PubMed ID: 9321519 [TBL] [Abstract][Full Text] [Related]
20. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats. Kumagai Y; Lin LY; Hiratsuka A; Narimatsu S; Suzuki T; Yamada H; Oguri K; Yoshimura H; Cho AK Mol Pharmacol; 1994 Feb; 45(2):359-65. PubMed ID: 7906857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]